Literature DB >> 9223522

Human immunodeficiency virus type 1 nucleocapsid protein specifically stimulates Mg2+-dependent DNA integration in vitro.

S Carteau1, S C Batson, L Poljak, J F Mouscadet, H de Rocquigny, J L Darlix, B P Roques, E Käs, C Auclair.   

Abstract

The integrase (IN) protein of the human immunodeficiency virus mediates integration of the viral DNA into the cellular genome. In vitro, this reaction can be mimicked by using purified recombinant IN and model DNA substrates. IN mediates two reactions: an endonucleolytic cleavage at each 3' end of the proviral DNA (terminal cleavage) and the joining of the linear viral DNA to 5' phosphates in the target DNA (strand transfer). Previous investigators have shown that purified IN requires Mn2+ or Mg2+ to promote strand transfer in vitro, although Mg2+ is the likely metal cofactor in vivo. IN activity in the presence of Mg2+ in vitro requires high IN concentrations and low concentrations of salt. Here, we show that the viral nucleocapsid protein NCp7 allows efficient IN-mediated strand transfer in the presence of Mg2+ at low enzyme concentrations. This potentiating effect appears to be unique to NCp7, as other small DNA-binding proteins, while capable of stimulating integration in the presence of Mn2+, all failed to stimulate strand transfer in the presence of Mg2+.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9223522      PMCID: PMC191888     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Retroviral integrase functions as a multimer and can turn over catalytically.

Authors:  K S Jones; J Coleman; G W Merkel; T M Laue; A M Skalka
Journal:  J Biol Chem       Date:  1992-08-15       Impact factor: 5.157

Review 2.  Integration of retroviral DNA.

Authors:  P O Brown
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

3.  Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers.

Authors:  H De Rocquigny; C Gabus; A Vincent; M C Fournié-Zaluski; B Roques; J L Darlix
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-15       Impact factor: 11.205

4.  Correct integration of retroviral DNA in vitro.

Authors:  P O Brown; B Bowerman; H E Varmus; J M Bishop
Journal:  Cell       Date:  1987-05-08       Impact factor: 41.582

5.  Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.

Authors:  S Carteau; J F Mouscadet; H Goulaouic; F Subra; C Auclair
Journal:  Arch Biochem Biophys       Date:  1993-02-01       Impact factor: 4.013

6.  Retroviral DNA integration directed by HIV integration protein in vitro.

Authors:  F D Bushman; T Fujiwara; R Craigie
Journal:  Science       Date:  1990-09-28       Impact factor: 47.728

7.  Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity.

Authors:  P A Sherman; J A Fyfe
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

8.  First large scale chemical synthesis of the 72 amino acid HIV-1 nucleocapsid protein NCp7 in an active form.

Authors:  H de Rocquigny; D Ficheux; C Gabus; M C Fournié-Zaluski; J L Darlix; B P Roques
Journal:  Biochem Biophys Res Commun       Date:  1991-10-31       Impact factor: 3.575

9.  Human immunodeficiency virus integration in a cell-free system.

Authors:  V Ellison; H Abrams; T Roe; J Lifson; P Brown
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

10.  Retroviral DNA integration: structure of an integration intermediate.

Authors:  T Fujiwara; K Mizuuchi
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

View more
  48 in total

1.  Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon.

Authors:  S L Martin; F D Bushman
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Retroviral cDNA integration: stimulation by HMG I family proteins.

Authors:  L Li; K Yoder; M S Hansen; J Olvera; M D Miller; F D Bushman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  Asymmetric processing of human immunodeficiency virus type 1 cDNA in vivo: implications for functional end coupling during the chemical steps of DNA transposition.

Authors:  H Chen; A Engelman
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

4.  Functional replacement of nucleocapsid flanking regions by heterologous counterparts with divergent primary sequences: effects of chimeric nucleocapsid on the retroviral replication cycle.

Authors:  William Fu; Wei-Shau Hu
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

5.  Correct integration of model substrates by Ty1 integrase.

Authors:  S P Moore; D J Garfinkel
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Cofactors for human immunodeficiency virus type 1 cDNA integration in vitro.

Authors:  Kui Gao; Robert J Gorelick; Donald G Johnson; Frederic Bushman
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

7.  Construction and analysis of cells lacking the HMGA gene family.

Authors:  Brett Beitzel; Frederic Bushman
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

8.  Distinct nucleic acid interaction properties of HIV-1 nucleocapsid protein precursor NCp15 explain reduced viral infectivity.

Authors:  Wei Wang; Nada Naiyer; Mithun Mitra; Jialin Li; Mark C Williams; Ioulia Rouzina; Robert J Gorelick; Zhengrong Wu; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2014-05-09       Impact factor: 16.971

9.  The (52-96) C-terminal domain of Vpr stimulates HIV-1 IN-mediated homologous strand transfer of mini-viral DNA.

Authors:  Julien Bischerour; Patrick Tauc; Hervé Leh; Hugues de Rocquigny; Bernard Roques; Jean-François Mouscadet
Journal:  Nucleic Acids Res       Date:  2003-05-15       Impact factor: 16.971

10.  Mutations in human immunodeficiency virus type 1 nucleocapsid protein zinc fingers cause premature reverse transcription.

Authors:  James A Thomas; William J Bosche; Teresa L Shatzer; Donald G Johnson; Robert J Gorelick
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.